Neuroimmunological and neurogenetic tests
We perform neuroimmunological and neurogenetic tests, as well as diagnostic tests of oncological diseases in co-operation with laboratories in Germany, Great Britain and Estonia. These tests enable diagnosis within the shortest possible notice or early diagnosis of disease risks that enable early therapy or preventive procedures.
Duration of the examination
Approximately 5-10 minutes.
No preliminary preparation is required.
Test samples of blood from the vein. The examination is painless.
There are no limitations.
Advantages of the method
A possibility of quick tests for the early diagnosis or detection of disease risks.
Depending on the specific nature of tests, the patient will receive test results within 7-30 days.
The test samples of blood taken from the vein serve as the basis for the examination. The specific nature of the test involves laboratory testing of the blood sample. Depending on the specific nature of tests, the blood samples are sent to a laboratory that specialises in the performance of the particular tests by using air courier mail.
Tests for the diagnosis of autoimmune and oncological diseases
Onconeural and surface receptor antibodies are determined in the event of various oncological and autoimmune nervous system diseases, for instance:
- tumours of various localisation;
- autoimmune polyneuropathy;
- A disease of the autonomous nervous system;
- autoimmune encephalitis/meningitis;
- demyelinating diseases;
- central and peripheral nervous system diseases of unspecified origin.
Examinations that are performed to determine the potential disease that is caused by changes in the genes is called genetic testing. We offer a wide range of genetic tests in co-operation with genetic laboratories in Estonia and Germany.
These tests are performed in the event of a particular genetic disease, as well as in absolutely healthy people to exclude common mutations.
The principal method is based on the approach of sequence determination, including sequencing that permits the detection of disease mutations and changes in the genes precisely and with a high level of credibility.
Diseases of central, as well as peripheral nervous system disorders could be genetically determined:
- balance and co-ordination disorders;
- diseases that affect muscle strength of the patient;
- muscle diseases;
- diseases that are associated with the patient’s memory and behaviour;
Tests, in the event of suspected Fabry or Pompe disease
Tests, in the event of suspected Fabry or Pompe disease may be performed at GK Neiroklīnika. These are congenital diseases with the following symptoms or manifestations: muscle weakness, dyspnoea, stroke, polyneuropathy, renal failure, especially in the cases where young people are ill.